Catchup for the new visitors12 Nov 2020 11:01
This is just off the top of my head, welcome others fleshing out, but it would be worth recounting just what exactly IS due for new visitors here:
1, CDX licencing with Eli, Development agreement extended to End December so they can pick one antibody to licence. Wording has been quite explicit here, there was no mention of testing to see if it works or discussions over the licence, it reads like they have a pocket full of cash, they are going to a car showroom to buy a car but they want a final test drive before they buy. Vlad et all are very keen for 2020 to be an inflection year so dont be surprised to see them squeeze the licencing in before EOY. I think its going to be January because there has been chat of a "licencing agreement" period, but is that still the case? Maybe that was just a stalling tactic while they waited for the labs to re-open, maybe the licence is ready to go pending Antibody ID.
2, SAFE-HEMO-CAR-T - Expecting a partner for this, PROBABLY add to existing sponsored agreement with Penn, probably coincide with results of successful completion of in vivo and in vitro testing.
3, HEMO-CAR-T - The agreement with Penn was clinical readyness, they have had a few months now, expect news soon on this which could be either IND application or even completion of the 30 day waiting period or announcement of a clinical trial.
4, Covid - Who knows, Vlad very bullish but also very secretive about whats going on.
5, Partner revenue streams - Orgenesis have been making the news, there are existing licencing agreements with them for 20% of related work, we could see an income here in the not too distant future.
6, HuPHEC - Think on hold? But if Belgium decides to promote growth and stimulate the economy Hemo were already in discussions re grant for the Cell bank, dont be surprised to see this come back in play unexpectedly.
7. The Mice - Vlad has stated the mice are of interest to big pharma, but looks like they are not actively selling them focusing instead on CAR-T and CDX. But when the mice have been proven they will be massively attractive to other big pharma sitting on lots of abandoned or stalled trials where these mice can be used to test safety
8, Lupus - Again with Eli Lilly, been quiet recently but we could have news any time.
9, CDX for ALL - From the wording for CDX licence HemoGenyx has a number of antibodies. They have clearly landed on something that works, when they complete AML licencing with Eli Lilly expect to see licencing of other antibodies following in short order once the mice have been proven. From the wording I believe they can licence OTHER AML antibodies to other pharma also?
10, T-Shirts, we have all seen them in the video, IF/When vlad has the time I am sure an online merchandise portal will be added to hemogenyx.